Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04456660Unknown

Comprehensive Assessment of Risks for Miscarriage.

Role: lead

NCT05820464Unknown

Diastolic Deceleration Area in Early-onset FGR

Role: lead

NCT05837195Unknown

Diastolic Deceleration Area in Late-onset FGR

Role: lead

NCT04447248Completed

qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses

Role: lead

All 4 trials loaded